{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:26:11Z","timestamp":1793085971813,"version":"4.5.0"},"reference-count":82,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1097\/hjh.0b013e3280127948","type":"journal-article","created":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T04:03:39Z","timestamp":1173153819000},"page":"731-741","source":"Crossref","is-referenced-by-count":142,"title":["Antioxidant activity of carvedilol in cardiovascular disease"],"prefix":"10.1097","volume":"25","author":[{"given":"Paresh","family":"Dandona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husam","family":"Ghanim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210208","first-page":"214","article-title":"Oxidative stress and heart failure","volume":"96","author":"Byrne","year":"2003","journal-title":"Arch Mal Coeur Vaiss"},{"key":"R2-1-20210208","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2174\/1570161054368607","article-title":"Role of oxidative\u2013nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure","volume":"3","author":"Ungvari","year":"2005","journal-title":"Curr Vasc Pharmacol"},{"key":"R3-1-20210208","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.RES.87.10.840","article-title":"Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress","volume":"87","author":"Cai","year":"2000","journal-title":"Circ Res"},{"key":"R4-1-20210208","doi-asserted-by":"crossref","first-page":"860","DOI":"10.7326\/0003-4819-123-11-199512010-00009","article-title":"The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data","volume":"123","author":"Jha","year":"1995","journal-title":"Ann Intern Med"},{"key":"R5-1-20210208","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/S0140-6736(03)13637-9","article-title":"Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials","volume":"361","author":"Vivekananthan","year":"2003","journal-title":"Lancet"},{"key":"R6-1-20210208","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jama.293.11.1338","article-title":"Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial","volume":"293","author":"Lonn","year":"2005","journal-title":"JAMA"},{"key":"R7-1-20210208","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00005344-200101000-00006","article-title":"Antioxidant properties of carvedilol and metoprolol in heart failure: a double-blind randomized controlled trial","volume":"37","author":"Arumanayagam","year":"2001","journal-title":"J Cardiovasc Pharmacol"},{"key":"R8-1-20210208","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1527-5299.2002.00718.x","article-title":"Carvedilol: a nonselective beta blocking agent with antioxidant properties.","volume":"8","author":"Book","year":"2002","journal-title":"Congest Heart Fail"},{"key":"R9-1-20210208","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/00005344-199604000-00012","article-title":"Protective effects of carvedilol, a vasodilating beta-adrenoceptor blocker, against in vivo low density lipoprotein oxidation in essential hypertension","volume":"27","author":"Maggi","year":"1996","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl 1","key":"R10-1-20210208","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1023\/A:1007735729121","article-title":"Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure","volume":"11","author":"Ruffolo","year":"1997","journal-title":"Cardiovasc Drugs Ther"},{"key":"R11-1-20210208","first-page":"92","article-title":"Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger","volume":"263","author":"Yue","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"R12-1-20210208","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1161\/01.CIR.101.2.122","article-title":"Carvedilol inhibits reactive oxygen species generation by leukocytes and oxidative damage to amino acids","volume":"101","author":"Dandona","year":"2000","journal-title":"Circulation"},{"key":"R13-1-20210208","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.amjmed.2003.10.029","article-title":"Effects of carvedilol on oxidative stress in polymorphonuclear and mononuclear cells in patients with essential hypertension","volume":"116","author":"Yasunari","year":"2004","journal-title":"Am J Med"},{"key":"R14-1-20210208","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/met.2004.2.155","article-title":"Classical anti-oxidants (scavengers) versus biological anti-oxidants (suppressors of ROS generation): a novel way to explain the anti-oxidant paradox","volume":"2","author":"Dandona","year":"2005","journal-title":"Metab Syndr Relat Disord"},{"key":"R15-1-20210208","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","article-title":"Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): randomised controlled trial","volume":"362","author":"Poole-Wilson","year":"2003","journal-title":"Lancet"},{"key":"R16-1-20210208","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1001\/jama.292.18.2227","article-title":"Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial","volume":"292","author":"Bakris","year":"2004","journal-title":"JAMA"},{"key":"R17-1-20210208","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ahj.2004.10.002","article-title":"The effect of metoprolol and carvedilol on cause-specific mortality in chronic heart failure patients. The Carvedilol or Metoprolol European Trial","volume":"149","author":"Torp-Pedersen","year":"2005","journal-title":"Am Heart J"},{"key":"R18-1-20210208","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0014-2999(00)00641-5","article-title":"Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model","volume":"406","author":"Gao","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"R19-1-20210208","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0735-1097(98)00101-6","article-title":"Increased oxidative stress in patients with congestive heart failure","volume":"31","author":"Keith","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"R21-1-20210208","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1161\/01.CIR.0000158483.13093.9D","article-title":"Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation","volume":"111","author":"Dandona","year":"2005","journal-title":"Circulation"},{"issue":"Suppl 1","key":"R22-1-20210208","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0033-0620(98)80027-3","article-title":"Novel mechanisms in the treatment of heart failure: inhibition of oxygen radicals and apoptosis by carvedilol","volume":"41","author":"Feuerstein","year":"1998","journal-title":"Prog Cardiovasc Dis"},{"key":"R23-1-20210208","doi-asserted-by":"crossref","first-page":"41L","DOI":"10.1016\/S0002-9149(97)00847-3","article-title":"Protective effects of carvedilol in the myocardium","volume":"80","author":"Feuerstein","year":"1997","journal-title":"Am J Cardiol"},{"key":"R24-1-20210208","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1527-5299.2002.00717.x","article-title":"Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure","volume":"8","author":"Sorescu","year":"2002","journal-title":"Congest Heart Fail"},{"key":"R25-1-20210208","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/01.RES.85.4.357","article-title":"Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium","volume":"85","author":"Ide","year":"1999","journal-title":"Circ Res"},{"key":"R26-1-20210208","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/01.RES.85.5.437","article-title":"Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure","volume":"85","author":"Ekelund","year":"1999","journal-title":"Circ Res"},{"key":"R27-1-20210208","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1161\/hc4501.098928","article-title":"Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy","volume":"104","author":"Cappola","year":"2001","journal-title":"Circulation"},{"key":"R28-1-20210208","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/01.HYP.0000032031.30374.32","article-title":"Activation of NADPH oxidase during progression of cardiac hypertrophy to failure","volume":"40","author":"Li","year":"2002","journal-title":"Hypertension"},{"key":"R29-1-20210208","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1016\/S0735-1097(03)00471-6","article-title":"Increased myocardial NADPH oxidase activity in human heart failure","volume":"41","author":"Heymes","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R30-1-20210208","first-page":"E85","article-title":"Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors","volume":"86","author":"Guzik","year":"2000","journal-title":"Circ Res"},{"key":"R31-1-20210208","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1161\/01.CIR.0000018605.14470.DD","article-title":"Carvedilol decreases elevated oxidative stress in human failing myocardium","volume":"105","author":"Nakamura","year":"2002","journal-title":"Circulation"},{"key":"R32-1-20210208","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.97.4.363","article-title":"Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure","volume":"97","author":"Hornig","year":"1998","journal-title":"Circulation"},{"key":"R33-1-20210208","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbrc.2004.12.139","article-title":"Carvedilol effectively blocks oxidative stress-mediated downregulation of sarcoplasmic reticulum Ca2+-ATPase 2 gene transcription through modification of Sp1 binding","volume":"328","author":"Koitabashi","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"R34-1-20210208","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/01.CIR.100.4.346","article-title":"Effect of beta-blockers on free radical-induced cardiac contractile dysfunction","volume":"100","author":"Flesch","year":"1999","journal-title":"Circulation"},{"issue":"Suppl 1","key":"R35-1-20210208","first-page":"S22","article-title":"Neurohormonal activation, oxygen free radicals, and apoptosis in the pathogenesis of congestive heart failure","volume":"32","author":"Ruffolo","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"key":"R36-1-20210208","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1161\/01.CIR.99.22.2934","article-title":"Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis","volume":"99","author":"von Harsdorf","year":"1999","journal-title":"Circulation"},{"key":"R37-1-20210208","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/0735-1097(96)00140-4","article-title":"Role of oxidative stress in transition of hypertrophy to heart failure","volume":"28","author":"Dhalla","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"R38-1-20210208","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/01.RES.87.5.392","article-title":"Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress","volume":"87","author":"Kinugawa","year":"2000","journal-title":"Circ Res"},{"key":"R39-1-20210208","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0014-5793(99)00370-1","article-title":"Superoxide induces apoptosis in cardiomyocytes, but proliferation and expression of transforming growth factor-beta1 in cardiac fibroblasts","volume":"448","author":"Li","year":"1999","journal-title":"FEBS Lett"},{"key":"R40-1-20210208","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1527-3466.2001.tb00061.x","article-title":"Carvedilol: molecular and cellular basis for its multifaceted therapeutic potential","volume":"19","author":"Cheng","year":"2001","journal-title":"Cardiovasc Drug Rev"},{"key":"R41-1-20210208","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1056\/NEJM198904063201407","article-title":"Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity","volume":"320","author":"Steinberg","year":"1989","journal-title":"N Engl J Med"},{"key":"R42-1-20210208","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0021-9150(98)00146-4","article-title":"Dual effects of the antioxidant agents probucol and carvedilol on proliferative and fatty lesions in hypercholesterolemic rabbits","volume":"141","author":"Donetti","year":"1998","journal-title":"Atherosclerosis"},{"key":"R43-1-20210208","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1046\/j.1523-1755.2002.00123.x","article-title":"Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB","volume":"61","author":"Onozato","year":"2002","journal-title":"Kidney Int"},{"key":"R44-1-20210208","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/jn\/132.5.897","article-title":"Dietary glutathione protects rats from diabetic nephropathy and neuropathy","volume":"132","author":"Ueno","year":"2002","journal-title":"J Nutr"},{"key":"R45-1-20210208","doi-asserted-by":"crossref","first-page":"26734","DOI":"10.1074\/jbc.272.42.26734","article-title":"Hydroxyl radicals depolymerize glomerular heparan sulfate in vitro and in experimental nephrotic syndrome","volume":"272","author":"Raats","year":"1997","journal-title":"J Biol Chem"},{"key":"R46-1-20210208","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1464-5491.2001.00416.x","article-title":"Lipid hydroperoxide and markers of renal disease susceptibility in African-Caribbean and Caucasian patients with Type 2 diabetes mellitus","volume":"18","author":"Mehrotra","year":"2001","journal-title":"Diabet Med"},{"key":"R47-1-20210208","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1365-2796.2003.01280.x","article-title":"Microalbuminuria and oxidative stress in essential hypertension","volume":"255","author":"Giner","year":"2004","journal-title":"J Intern Med"},{"key":"R48-1-20210208","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/ki.1996.256","article-title":"Importance of nitric oxide in the control of renal hemodynamics","volume":"49","author":"Baylis","year":"1996","journal-title":"Kidney Int"},{"key":"R49-1-20210208","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial.","volume":"357","year":"2001","journal-title":"Lancet"},{"key":"R50-1-20210208","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group","volume":"334","author":"Packer","year":"1996","journal-title":"N Engl J Med"},{"key":"R51-1-20210208","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N Engl J Med"},{"key":"R52-1-20210208","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"R53-1-20210208","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF).","volume":"353","year":"1999","journal-title":"Lancet"},{"issue":"Suppl B","key":"R54-1-20210208","first-page":"B19","article-title":"Carvedilol: preclinical profile and mechanisms of action in preventing the progression of congestive heart failure","volume":"19","author":"Ruffolo","year":"1998","journal-title":"Eur Heart J"},{"key":"R55-1-20210208","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0006-2952(99)00417-7","article-title":"Antioxidant action of the antihypertensive drug, carvedilol, against lipid peroxidation","volume":"59","author":"Noguchi","year":"2000","journal-title":"Biochem Pharmacol"},{"issue":"Suppl F","key":"R56-1-20210208","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/eurheartj\/16.suppl_F.38","article-title":"Carvedilol, a novel multiple action antihypertensive agent with antioxidant activity and the potential for myocardial and vascular protection","volume":"16","author":"Feuerstein","year":"1995","journal-title":"Eur Heart J"},{"key":"R57-1-20210208","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0014-2999(98)00326-4","article-title":"Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model","volume":"351","author":"Feuerstein","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"R58-1-20210208","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0735-1097(00)00671-9","article-title":"Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction","volume":"36","author":"Wei","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R59-1-20210208","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00005344-200008000-00020","article-title":"A comparison of carvedilol and metoprolol antioxidant activities in vitro","volume":"36","author":"Lysko","year":"2000","journal-title":"J Cardiovasc Pharmacol"},{"key":"R60-1-20210208","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1023\/B:MCBI.0000021380.97941.78","article-title":"Cardioprotective effects of carvedilol on acute autoimmune myocarditis","volume":"259","author":"Yuan","year":"2004","journal-title":"Mol Cell Biochem"},{"issue":"Suppl A","key":"R61-1-20210208","first-page":"166A","article-title":"The distinct effect of carvedilol and metoprolol on the mitochondrial superoxide production under calcium overload of myocardium. Poster presented at the American College of Cardiology 54th Annual Session; 8 March 2005; Orlando, Florida","volume":"45","author":"Kametani","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R62-1-20210208","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0024-3205(99)00362-8","article-title":"Protective effects of carvedilol against doxorubicin-induced cardiomyopathy in rats","volume":"65","author":"Matsui","year":"1999","journal-title":"Life Sci"},{"key":"R63-1-20210208","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.taap.2004.04.005","article-title":"Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity","volume":"200","author":"Oliveira","year":"2004","journal-title":"Toxicol Appl Pharmacol"},{"key":"R64-1-20210208","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0008-6363(99)00369-7","article-title":"Carvedilol prevents epinephrine-induced apoptosis in human coronary artery endothelial cells: modulation of Fas\/Fas ligand and caspase-3 pathway","volume":"45","author":"Romeo","year":"2000","journal-title":"Cardiovasc Res"},{"key":"R65-1-20210208","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/01.RES.82.2.166","article-title":"Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia\/reperfusion-induced cardiomyocyte apoptosis by carvedilol","volume":"82","author":"Yue","year":"1998","journal-title":"Circ Res"},{"key":"R66-1-20210208","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0014-2999(98)00494-4","article-title":"SB 211475, a metabolite of carvedilol, reduces infarct size after myocardial ischemic and reperfusion injury in rabbits","volume":"356","author":"Brunvand","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"R67-1-20210208","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0008-6363(03)00459-0","article-title":"Carvedilol, a new antioxidative beta-blocker, blocks in vitro human peripheral blood T cell activation by downregulating NF-kappaB activity","volume":"59","author":"Yang","year":"2003","journal-title":"Cardiovasc Res"},{"key":"R68-1-20210208","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1081\/IMM-120019207","article-title":"Carvedilol modulates in-vitro granulocyte\u2013macrophage colony-stimulating factor-induced interleukin-10 production in U937 cells and human monocytes","volume":"32","author":"Cheng","year":"2003","journal-title":"Immunol Invest"},{"key":"R69-1-20210208","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0041-1345(02)04001-0","article-title":"Effect of carvedilol alone or in the presence of cyclosporine on the migration of vascular smooth muscle cell of rat","volume":"35","author":"Kim","year":"2003","journal-title":"Transplant Proc"},{"key":"R70-1-20210208","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1442-200X.2006.02156.x","article-title":"Urinary oxidative stress markers in young patients with type 1 diabetes","volume":"48","author":"Hata","year":"2006","journal-title":"Pediatr Int"},{"key":"R71-1-20210208","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0014-5793(97)01273-8","article-title":"New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus","volume":"417","author":"Leinonen","year":"1997","journal-title":"FEBS Lett"},{"key":"R72-1-20210208","doi-asserted-by":"crossref","first-page":"955","DOI":"10.7326\/0003-4819-126-12-199706150-00004","article-title":"Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial","volume":"126","author":"Giugliano","year":"1997","journal-title":"Ann Intern Med"},{"key":"R73-1-20210208","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1161\/01.CIR.99.20.2645","article-title":"Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure","volume":"99","author":"Kukin","year":"1999","journal-title":"Circulation"},{"key":"R74-1-20210208","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1042\/CS20030172","article-title":"Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chf oxidant stress: implications for beta blocker selection","volume":"105","author":"Chin","year":"2003","journal-title":"Clin Sci (Lond)"},{"key":"R75-1-20210208","first-page":"212","article-title":"Efficacy of carvedilol in mild to moderate essential hypertension and effects on microalbuminuria: a multicenter, randomized, open-label, controlled study versus atenolol","volume":"12","author":"Marchi","year":"1995","journal-title":"Adv Ther"},{"key":"R76-1-20210208","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.amjmed.2003.10.029","article-title":"Effects of carvedilol on oxidative stress in polymorphonuclear and mononuclear cells in patients with essential hypertension","volume":"116","author":"Yasunari","year":"2004","journal-title":"Am J Med"},{"key":"R78-1-20210208","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0002-9149(00)00962-0","article-title":"Nadolol inhibits reactive oxygen species generation by leukocytes and linoleic acid oxidation","volume":"86","author":"Magsino","year":"2000","journal-title":"Am J Cardiol"},{"key":"R79-1-20210208","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/01.ATV.0000065234.70518.26","article-title":"Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells","volume":"23","author":"Mollnau","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R80-1-20210208","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/08038020410016557","article-title":"Experimental evidences of nitric oxide-dependent vasodilatory activity of nebivolol, a third-generation beta-blocker","volume":"1","author":"Ignarro","year":"2004","journal-title":"Blood Press Suppl"},{"key":"R81-1-20210208","first-page":"3257","article-title":"Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?","volume":"86","author":"Dandona","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R82-1-20210208","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/01.HYP.36.3.430","article-title":"Troglitazone reduces reactive oxygen species generation by leukocytes and lipid peroxidation and improves flow-mediated vasodilatation in obese subjects","volume":"36","author":"Garg","year":"2000","journal-title":"Hypertension"},{"key":"R83-1-20210208","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/eurheartj\/ehi115","article-title":"Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)","volume":"26","author":"Flather","year":"2005","journal-title":"Eur Heart J"},{"key":"R84-1-20210208","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1345\/aph.1G708","article-title":"Nebivolol: a third-generation beta-adrenergic blocker","volume":"40","author":"Veverka","year":"2006","journal-title":"Ann Pharmacother"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004872-200704000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:31:32Z","timestamp":1786033892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004872-200704000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e3280127948","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}